Pedro Miguela-Villoldo

Dr. Pedro Miguela-Villoldo

Healthcare-Associated Infections Unit, Instituto de Salud Carlos III, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2017 in Eurosurveillance
Verified
Journal Article
Open access
Marta HernandezMarta Hernandez
Marta Hernandez
MIM Rocío Iglesias
M Rocío Iglesias
DRDavid Rodríguez-Lázaro
David Rodríguez-Lázaro
AGAlejandro Gallardo
Alejandro Gallardo
NQNarciso Martín Quijada
Narciso Martín Quijada
AQAlberto Quesada
Alberto Quesada
Colistin resistance genes mcr-3 and mcr-1 have been detected in an Escherichia coli isolate from cattle faeces in a Spanish slaughterhouse in 2015. The sequences of both genes hybridised to same plasmid band of ca 250 kb, although colistin resistance was non-mobilisable. The isolate was producing extended-spectrum beta-lactamases and belonged to serotype O9:H10 and sequence type ST533. Here we report an mcr-3 gene detected in Europe following earlier reports from Asia and the United States.

22 August 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
ASAlejandro Gallardo Soler
Alejandro Gallardo Soler
MUMaría Ugarte-Ruiz
María Ugarte-Ruiz
Marta HernandezMarta Hernandez
Marta Hernandez
PMPedro Miguela-Villoldo
Pedro Miguela-Villoldo
DRDavid Rodríguez-Lázaro
David Rodríguez-Lázaro
AQAlberto Quesada
Alberto Quesada
Plasmid-mediated colistin resistance (mcr) determinants are challenging the efficacy of polymyxins against Gram-negative pathogens. Among 10 mcr genes described so far, the major determinants mcr-1 and mcr-3 are found closely linked to hpap2 or dgkA genes, encoding a hypothetical phosphatidic acid phosphatase of type 2 (PAP2) and a diacylglycerol kinase, respectively, whose functions are still unknown. In this study, mcr-1, mcr-1–hpap2, mcr-3, and mcr-3–dgkA were expressed in Escherichia coli, and recombinant strains were analyzed to detect antimicrobial susceptibility and changes in the expression of genes involved in phospholipid metabolism. The mcr-1 or mcr-3 single genes were enough to drive growth on colistin selective media, although co-expression of linked genes conferred maximal antibiotic resistance. Expression of mcr determinants downregulated endogenous genes involved in lipopolysaccharide (LPS) modification or phospholipid recycling, although to different extents of repression: strong for arnB, ybjG, and pmrR; medium for eptA, lpxT, and dgkA; small for bacA and pgpB. Four of these genes (bacA, lpxT, pgpB, and ybjG) encode undecaprenyl pyrophosphate (UPP) phosphatases. In these conditions, cells presented resistance against bacitracin, an antibiotic that sequesters UPP from PAP2 enzymes. The hpap2 and dgkA genes might play a role in colistin resistance by compensating for phospholipid metabolism functions altered during LPS modification by colistin resistance determinants.

17 March 2022 in Porcine Health Management
Verified
Journal Article
Open access
PDF file
PMPedro Miguela-Villoldo
Pedro Miguela-Villoldo
MMMiguel A. Moreno
Miguel A. Moreno
DRDavid Rodríguez-Lázaro
David Rodríguez-Lázaro
AGAlejandro Gallardo
Alejandro Gallardo
MHMarta Hernández
Marta Hernández
MUMaría Ugarte-Ruiz
María Ugarte-Ruiz
Background: Resistance to colistin was an uncommon phenomenon traditionally linked to chromosome point mutations, but since the first description of a plasmid-mediated colistin-resistance in late 2015, transmissible resistance to colistin has become a Public Health concern. Despite colistin is considered as a human last resort antibiotic, it has been commonly used in swine industry to treat post-weaning diarrhoea in piglets. However, the progressively increase of colistin resistance during the last decade led to the Spanish Medicines and Healthcare Products Agency (AEMPS) to launch a strategic and voluntary plan aimed to reduce colistin consumption in pig production. Our longitudinal study (1998–2021) aimed to evaluate the trend of colistin resistance mediated through the mcr-1 mobile gene in Spanish food-producing pig population and compare it with published polymyxin sales data in veterinary medicine to assess their possible relationships. Results: The first mcr-1 positive sample was observed in 2004, as all samples from 1998 and 2002 were mcr-1 PCR-negative. We observed a progressive increase of positive samples from 2004 to 2015, when mcr-1 detection reached its maximum peak (33/50; 66%). From 2017 (27/50; 54%) to 2021 (14/81; 17%) the trend became downward, reaching percentages significantly lower than the 2015 peak (p < 0.001). The abundance of mcr-1 gene in PCR-positive samples showed a similar trend reaching the highest levels in 2015 (median: 6.6 × 104mcr-1 copies/mg of faeces), but decreased significantly from 2017 to 2019 (median 2.7 × 104, 1.2 × 103, 4.6 × 102mcr-1 copies/mg of faeces for 2017, 2018 and 2019, respectively), and stabilizing in 2021 (1.6 × 102mcr-1 copies/mg of faeces) with similar values than 2019. Conclusions: Our study showed the decreasing trend of colistin resistance associated to mcr-1 gene, after a previous increase from among 2004–2015, since the European Medicines Agency and AEMPS strategies were applied in 2016 to reduce colistin use in animals, suggesting a connection between polymyxin use and colistin resistance. Thus, these plans could have been effective in mcr-1 reduction, reaching lower levels than those detected in samples collected 17 years ago, when resistance to colistin was not yet a major concern.

1 April 2019 in Research in Veterinary Science
Verified
Journal Article
Closed access
PMPedro Miguela-Villoldo
Pedro Miguela-Villoldo
Marta HernandezMarta Hernandez
Marta Hernandez
MMMiguel Ángel Moreno
Miguel Ángel Moreno
DRDavid Rodríguez-Lázaro
David Rodríguez-Lázaro
AQAlberto Quesada
Alberto Quesada
MRMaría Ugarte Ruiz
María Ugarte Ruiz

19 April 2021 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
AGAlejandro Gallardo
Alejandro Gallardo
MIMaría-Rocío Iglesias
María-Rocío Iglesias
MUMaría Ugarte-Ruiz
María Ugarte-Ruiz
Marta HernandezMarta Hernandez
Marta Hernandez
PMPedro Miguela-Villoldo
Pedro Miguela-Villoldo
AQAlberto Quesada
Alberto Quesada
The use of colistin as a last-resort antimicrobial is compromised by the emergence of resistant enterobacteria with acquired determinants like mcr genes, mutations that activate the PmrAB system, and still unknown mechanisms. This work analyzed 74 Escherichia coli isolates from healthy swine, turkey, or bovine, characterizing their colistin resistance determinants.

1 November 2020 in Poultry Science
Verified
Journal Article
Open access
ARAgustín Rebollada-Merino
Agustín Rebollada-Merino
MRMaría Ugarte Ruiz
María Ugarte Ruiz
Marta HernandezMarta Hernandez
Marta Hernandez
PMPedro Miguela-Villoldo
Pedro Miguela-Villoldo
DADavid Abad
David Abad
ARAntonio Rodríguez-Bertos
Antonio Rodríguez-Bertos
Nutraceuticals are not only nutritionally beneficial for animals but also their use as feed supplements may reduce environmental contamination. The effect of fermented defatted “alperujo,” an olive oil by-product, supplementation on the intestinal health of broiler chickens was assessed by analyzing the intestinal mucosal morphology of the duodenum and the cecum. The microbiota of the cecum was also characterized by analyzing the V3-V4 region of the 16S rRNA gene on days 7, 14, 21, 28, 35, and 42. Supplemented broilers from 14 to 35 D of age showed an increase in villus height in the duodenum. This increase likely improved digestibility and absorption capacity during growth, leading to the observed increase in BW at day 35 of life. A progressive increase in crypt depth in both the duodenum and the cecum was also observed. This modification likely enhanced epithelial renewal, thus safeguarding the turnover capacity of the intestinal mucosa. Our molecular analysis of cecal microbiota suggests that this dietary supplement may favor the growth of certain bacteria and may control the spread of pathogenic bacteria by means of competitive exclusion.